251 related articles for article (PubMed ID: 1177347)
21. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of treatments in experimental toxoplasmosis].
Tassignon MJ; Brihaye M; De Meuter F; Vercruysse A; Van Hoof F; De Wilde F
Bull Soc Belge Ophtalmol; 1989; 230():59-72. PubMed ID: 2488436
[TBL] [Abstract][Full Text] [Related]
24. Treatment of acute Toxoplasma gondii infections in mice with diclazuril or a combination of diclazuril and pyrimethamine.
Lindsay DS; Rippey NS; Blagburn BL
J Parasitol; 1995 Apr; 81(2):315-8. PubMed ID: 7707217
[TBL] [Abstract][Full Text] [Related]
25. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
[TBL] [Abstract][Full Text] [Related]
26. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
Grossman PL; Remington JS
Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
[TBL] [Abstract][Full Text] [Related]
27. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).
Nguyen BT; Stadtsbaeder S
Br J Pharmacol; 1985 Jul; 85(3):713-6. PubMed ID: 3875381
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic future of trimethoprim-sulfamethoxazole in toxoplasmosis].
Nguyen BT; Stadtsbaeder S
Presse Med; 1983 Feb; 12(6):331-3. PubMed ID: 6221325
[No Abstract] [Full Text] [Related]
30. Chemotherapy of experimental toxoplasmosis with special reference to robenidine.
Bakhtari SK; Jíra J
Folia Parasitol (Praha); 1988; 35(3):193-8. PubMed ID: 2974008
[TBL] [Abstract][Full Text] [Related]
31. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models.
Dumas JL; Pizzolato G; Pechère JC
Int J Antimicrob Agents; 1999 Sep; 13(1):35-9. PubMed ID: 10563403
[TBL] [Abstract][Full Text] [Related]
33. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
Holland GN
Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
[No Abstract] [Full Text] [Related]
34. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
[TBL] [Abstract][Full Text] [Related]
35. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
Vischer WA
Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):398-408. PubMed ID: 4145848
[No Abstract] [Full Text] [Related]
37. Comparison of trimethoprim in combination with sulfadiazine or sulfamethoxazole in the treatment of respiratory infections.
Varde AB; Gaitonde AM; Tilve GH; Kale VV; Satoskar RS
J Postgrad Med; 1981 Jul; 27(3):159-62. PubMed ID: 7299704
[No Abstract] [Full Text] [Related]
38. Acute monosymptomatic aseptic meningitis caused by Toxoplasma gondii.
Vukmirovits G; Juhász P; Jankó M; Tóth L
Acta Paediatr Hung; 1985; 26(1):31-4. PubMed ID: 2580542
[TBL] [Abstract][Full Text] [Related]
39. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
Mahmoud MS
J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
[TBL] [Abstract][Full Text] [Related]
40. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
